Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Clinical trial NCT00516503 · COMPLETED

Trial details

NCT number: NCT00516503
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Neurotoxicity Pain Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2008-02-01
Primary completion: 2009-04-01
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.